Product/Brand |
Composition |
Pack |
Indications |
Tetanus Vaccine (adsorbed) - TT (BE
tt)
|
0.5 ml dose contains
|
0.5 ml amp
0.5 ml vial
5 ml vial
|
Active Immunization for Tetanus |
| Tetanus
toxoid |
: |
≥
5Lf to ≤25LF |
| Aluminium
phosphate |
: |
≥
5Lf |
| Thiomersal |
:
|
0.01%
w/v |
 |
Diphtheria,
w-Pertussis and
Tetanus Vaccine (adsorbed) – DTwP
(TRIPVAC)
|
0.5 ml dose contains |
0.5 ml amp
0.5 ml vial
5 ml vial
10 ml vial |
Immunization for Diphtheria, Pertussis
and Tetanus
|
| Diphtheria
toxoid |
: |
≥
20 Lf to ≤ 30Lf |
| Tetanus
toxoid |
: |
≥
5 Lf to ≤ 25 Lf |
| B.pertussis
(whole cell) |
: |
≥
4 IU |
| Aluminium
phosphate |
: |
≥
1.5 mg |
| Thiomersal
|
: |
0.01
% w/v |
|
Diphtheria and Tetanus Vaccine (adsorbed)
- DT (BIVAC)
|
0.5 ml dose contains |
0.5 ml amp
5 ml vial
10 ml vial |
Immunization for Diphtheria and Tetanus |
| Diphtheria
toxoid |
: |
≥ 20
Lf to ≤ 30 Lf |
| Tetanus
toxoid |
: |
≥ 5
Lf to ≤ 25 Lf |
| Aluminium
phosphate |
: |
≥ 1.5
mg |
| Thiomersal |
: |
0.01 %
w/v |
|
Diphtheria and Tetanus Vaccine (adsorbed)
for adults and adolescents- Td (BE Td)
|
0.5 ml dose contains |
0.5 ml vial
5 ml vial |
Immunization for Diphtheria and Tetanus
in adults and adolescents |
| Diphtheria
toxoid |
: |
≥ 2
Lf |
| Tetanus
toxoid |
: |
≥ 5
Lf to ≤ 25 Lf |
| Aluminium
phosphate |
: |
≥ 1.5
mg |
| Thiomersal |
: |
0.01 %
w/v |
|
Hepatitis B Vaccine (BEVAC)
|
0.5 ml dose contains : purified HBsAg
10 µg
Aluminium Hydroxide as Al+++ 0.25 mg
|
0.5 ml vial |
Immunization against
Hepatitis B
|
| Thiomersal
|
:
|
0.025
mg |
0.5 ml contains : purified HBsAg 10
µg
Aluminium Hydroxide as Al+++ 0.25 mg
|
5 ml vial |
| Thiomersal
|
:
|
0.025
mg |
1 ml dose contains : purified HBsAg
20 µg
Aluminium Hydroxide as Al+++ 0.5 mg
|
1 ml vial |
| Thiomersal
|
:
|
0.05
mg |
0.5 ml contains : purified HBsAg 20
µg
Aluminium Hydroxide as Al+++ 0.5 mg
|
10 ml vial
|
| Thiomersal
|
:
|
0.05
mg |
|
Inactivated Polio Vaccine (IPV) (ERAPOL)
|
0.5 ml dose contains |
0.5 ml vial
5 ml vial
|
Immunization against polio |
|
Inactivated Poliomyelitis Virus type
1 |
:
|
40 D
antigen units |
|
Inactivated Poliomyelitis Virus type
2 |
:
|
8 D antigen
units |
|
Inactivated Poliomyelitis Virus type
3 |
:
|
32 D
antigen units |
|
2-Phenoxye-thanol |
:
|
2.5 mg
|
|
Haemophillus Influenza Type b (Hib)
Conjugate Vaccine (Lyophilised) (HiBE)
|
0.5 ml dose contains |
0.5 ml vial |
Immunization against Haemophillus Influenza
type b infection in children of age
group of 6 weeks to 5 years |
Purified Capsular Polysaccharide (PRP)
From Haemophillus Influenza type b
(Strain 760705) --- 10 μg and
Tetanus Toxoid --- 19 to 33 μg
|
|
Combined Diphtheria, Tetanus, w-Pertussis,
Hepatitis B (Recombinant)
DTP+ Hep B - Tetravalent Vaccine (TRIPVAC
HB)
|
0.5 ml contains |
0.5 ml vial
5 ml vial |
Immunization for Diphtheria, Tetanus,
Pertussis and
Hepatitis B
|
| Diphtheria
Toxoid |
: |
≥ 30
IU |
| Tetanus
Toxoid |
: |
≥ 60
IU |
| B.pertussis
(whole cell) |
: |
≥ 4
IU |
| r-HBs
AG |
: |
- 10 μg |
| Al+++
(as AlPO4) |
: |
≤ 1.25
mg |
| Thiomersal
|
: |
0.01 %
w/v |
